Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy

Saini, K.S., Lanza, C., Romano, M. et al. (10 more authors) (2020) Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy. British Journal of Cancer, 123. pp. 694-697. ISSN: 0007-0920

Abstract

Metadata

Item Type: Article
Authors/Creators:
  • Saini, K.S.
  • Lanza, C.
  • Romano, M.
  • de Azambuja, E.
  • Cortes, J.
  • de las Heras, B.
  • de Castro, J.
  • Lamba Saini, M.
  • Loibl, S.
  • Curigliano, G.
  • Twelves, C.
  • Leone, M.
  • Patnaik, M.M.
Copyright, Publisher and Additional Information:

© Cancer Research UK 2020. This is an open access article under the terms of the Creative Commons Attribution License (CC-BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
Dates:
  • Accepted: 4 June 2020
  • Published (online): 22 June 2020
  • Published: 1 September 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Date Deposited: 27 Oct 2025 11:01
Last Modified: 27 Oct 2025 11:01
Status: Published
Publisher: Springer Nature
Identification Number: 10.1038/s41416-020-0948-x
Related URLs:
Sustainable Development Goals:
  • Sustainable Development Goals: Goal 3: Good Health and Well-Being
Open Archives Initiative ID (OAI ID):

Export

Statistics


CORE (COnnecting REpositories)